Healthcare Regulatory Affairs Outsourcing Market expected at a CAGR of ~ 13.5% & US$ 2.54 Bn during the forecast period 2022–2028

Global Healthcare Regulatory Affairs Outsourcing Market: Overview

Consistent evaluation of cost-saving options such as regulatory affairs outsourcing is carried out by several drug/device manufacturers in order to streamline their operations and ensure product safety and maintain public healthcare.\

The global health care regulatory affairs outsourcing market includes services like regulatory writing and publishing, clinical trial applications, etc. A new research report by Future Market Insights provides an in-depth analysis of the global regulatory affairs outsourcing market. This comprehensive research report is titled ‘Healthcare Regulatory Affairs Outsourcing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 – 2028’. It includes all the crucial numbers of the market along with the dynamics impacting it. According to this research report the global healthcare regulatory affairs outsourcing market is expected to reach a market revenue of over US$ 2,000 Mn by the end of 2025, growing at a stellar CAGR of 12.2% over the forecast period. The growth of the market is triggered largely by the increasing investments in the healthcare industry along with the increase in research and developments taking place. Also increasing focus on CMOs and CROs has been observed in the market. The reports also depicts that Asia Pacific is expected to lead the global healthcare regulatory affairs outsourcing market during 2017-2025. Low cost, fast turnaround time and easy availability of the skilled and trained professionals will further result in increased outsourcing in APAC countries.

2012-2021 Healthcare Regulatory Affairs Outsourcing Market in Comparison to 2022-2028 Demand Outlook

Demand for healthcare regulatory affairs outsourcing is projected to increase at an impressive 13.5% CAGR, in comparison with the 10.8% CAGR registered between 2012 and 2021.

The expansion of the healthcare sector worldwide is compelling biotechnology and pharmaceutical companies to outsource regulatory affairs to save costs and leverage the expertise available with contract research organizations (CROs). This process allows companies to save time and improve their core competencies, which is a chief driver of the market.

Regulatory support is available for most of the processes across clinical trials, such as manufacturing and controls (CMC), medial report writing, regulatory chemistry, data management, country regulatory affairs, regulatory strategy, and labeling & liaison.

Outsourcing these non-core activities to experts enables healthcare organizations to focus on their marketing and research and development activities. In the long run, companies can benefit from product approvals, optimized reimbursements, and increased productivity.
Owing to these factors, the market is anticipated to witness an upward trajectory in growth over the forecast period, opines FMI.

healthcare regulatory affairs outsourcing market

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-6355

Global Healthcare Regulatory Affairs Outsourcing Market:  Segmental Analysis

  • Based on End Users, mid-size pharmaceutical companies leads the market with a high market size expected during the forecast period, growing at a CAGR of 13.8% during the forecast period. However Biotechnology companies are also progressing at a high rate and is expected to give a strong competition to mid-size pharma companies in terms of growth rate expected during the forecast period.
  • On the basis of Services, regulatory writing and publishing service segment is expected to dominate the market with a market share of over US$ 800 Mn by the end of 2025. However the segment is much behind the other services in terms of growth rate. Regulatory consulting and legal representation is the service which is expected to register fastest growth at a CAGR of 14.3% during the forecast period.
  • In terms of Region, Asia Pacific is expected to be the largest region with a high market valuation. However, North America is also expected to give tough competition to APAC. Both these regions are expected to reflect a valuation higher than US$ 720 Mn by 2025 end. However North America lags behind in the race with comparatively less CAGR expected during the forecast period. Whereas, Asia Pacific is expected to register the fastest growth rate of 13.2% CAGR during the forecast period.

Global Healthcare Regulatory Affairs Outsourcing Market:  Competitive Landscape

The research report consists of a brief profile of all the major players leading in the industry. It also includes a SWOT analysis of these companies. The leading players mentioned in the report includes companies like Clinilabs, Inc., Accell Clinical Research, LLC.,  Freyr Solutions, The Weinberg Group Inc., Covance, Inc., (LabCorp), Pharmaceutical Product Development LLC, ICON plc., Sciformix Corporation etc.

Healthcare Regulatory Affairs Outsourcing Market by CategoryServices:

  • Regulatory Writing and Publishing
  • Regulatory Submissions
  • Clinical Trial Applications
  • Product Registrations
  • Regulatory Consulting and Legal Representation

End User:

  • Mid-Size Pharmaceutical Companies
  • Large Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Devices Manufacturer
  • Food & Beverage Companies

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Mobile Clinics Market Covid-19 Impact Analysis, Opportunities, Threats, Drivers, Restraints, Trends, Applications, And Growth Forecast To 2030

Mobile health clinics market is expected to have significant growth during the forecast period. It helps in attaining Universal Health Coverage by treating isolated groups of society. A mobile clinic is flexible and viable option to overcome lack of healthcare infrastructure issue in rural areas.

Mobile clinics market can reach out to the marginalised population of remote areas that are cut-off from mainstream health services. This concept of Mobile Clinic aims to bring services to the patient rather.

As per World Health Organization norms, public spending on healthcare has to be 2.5-5.0 per cent of the GDP of the country. Whereas, the majority of developing and under-developed countries fail to achieve the target. Regions with poor health infrastructure rely on Mobile clinics market to provide healthcare services covering a maximum of its population.

With the incidence of COVID-19 across the globe, the demand for mobile clinics market has drastically increased. Mobile clinics are used for diagnostics and screening purpose amid coronavirus to cover the maximum population of the country.

Lockdown has been implemented in several countries to restrict the movement of citizens, mobile clinics market is working towards providing necessary healthcare facilities to the population.

Mobile Clinics Market: Drivers and Restraints

Mobile clinics market provides innovative healthcare delivery solution covering the maximum population of the region creating demand for the market. Increased prevalence of chronic diseases in rural and remote areas lead to a rise in demand for mobile clinics market.

Implementation of government schemes for screening and chronic disease management in rural areas will propel mobile clinic market growth in the coming decade. Portable nature of mobile clinic is one of the key factor driving the market growth.

Limited patient catering capacity restraints mobile clinics market growth. The mobile clinic can cater to a specified number of equipment and treatment options, challenging market growth.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12141

Mobile Clinics Market: Overview

Rise in demand to provide healthcare facilities in rural remote areas has boost demand for mobile clinics market. Based on clinic type, OPD type mobile clinic is the highest revenue-generating with the highest sales.

Following OPD, diagnostic/screening type mobile clinic is second leading in mobile clinics market. Maternal health mobile clinics are expected to have significant growth during the forecast period with increased awareness.

Single exam room and double exam room design type mobile clinics hold the majority share in mobile clinics market. Whereas, mobile medical vans generate the highest revenue followed by mobile medical bus for mobile clinics market.

Mobile Clinics Market: Region-wise Outlook

North America will continue to dominate mobile clinics market during the forecast period due to higher healthcare expenditure. Europe is the second leading region in mobile clinics market due to government initiatives to make healthcare accessible, hence increasing demand for the mobile clinic.

Asia-Pacific region is expected to have the highest CAGR during the forecast period. Mobile clinics market has higher demand with increased product penetration and a huge percentage of the rural area without basic health facilities in the Asia-Pacific region. Whereas, the Middle East and Africa are still an untapped region for Mobile Clinics Market.

Mobile Clinics Market: Key Market Participants

Major players in mobile clinics market include

  • MedicalExpo
  • ADI Mobile Health Inc.
  • Phoenix Modular
  • LifeLine Mobile
  • Medical Coaches Inc.
  • Odulair LLC
  • Matthews Specialty Vehicles Inc.
  • EMS Mobile Sistemler
  • Johnson Medical
  • Mobile Healthcare Facilities
  • GE Healthcare
  • Farber Specialty Vehicles
  • CVR Industries
  • Kentucky trailer technologies
  • Amtex Corporation
  • Phoenix Modular
  • MinFound Medical Systems
  • Independent Modular Builders Alliance

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12141

The research report on mobile clinics market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report on mobile clinics market provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (India, ASEAN, Australia & New Zealand)
  • China
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Mobile Clinics Market: Segmentation

By clinic type:

  • Maternal Health
  • Neonatal and Infant Health
  • Child and Adolescent Health
  • Reproductive Health and Contraceptive Services
  • Mental Health
  • Dental Care
  • ENT
  • Geriatric Care
  • OPD
  • Diagnostic/screening
  • Emergency care

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12141

By design layout:

  • Single exam room
  • Double exam room
  • Triple exam room

By vehicle type:

  • Mobile medical vans
  • Mobile medical train
  • Mobile medical bus
  • Mobile medical shipping containers

Vascular Patches Market By Application, By End User and By Region, Industry Analysis, Revenue Opportunity, Competitive Analysis and Forecast 2021-2030

Vascular patches are the microporous patch of bio-compatible polyester-urethane patches which are used for vascular surgeries for suturing closure. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of deaths, claiming approximately 17.9 million lives every year.

Vascular patches are highly biocompatible, minimally infectious, low suture line bleeding by its highly elastic material and excellent incorporation of tissue and doesn’t require impregnation or pre-clotting and favorable handling properties.

The global vascular patches market is expected to grow lucratively in coming years, due to the high prevalence of cardiac complications, technological and healthcare increments. Coronavirus has negatively impacted the vascular patches market by drawing global attention towards the massive influx of the coronavirus patients, which ultimately shifted the medical, research attentions and investments towards it from the other disease areas.

Also, the lockdown imposed during the pandemic outbreak resulted in the shutdown of labs, offices, halted supplies and restricted the regular visits of patients of other diseases such as cardiac diseases.

Increasing prevalence of cardiac diseases driven by the sedentary lifestyle, stress and other disruptive habits, and the surging medical advancements, high adoption rate of vascular patches due to their excellent biocompatibility, and awareness are driving the growth of vascular patch market.

The rising cases of ischemia stroke, expanding geriatric populations are transcending the needs for stenosis and surgeries of autologous vessels including saphenous vein and internal thoracic artery. The advanced surgical technologies, major players with their deliberated research to develop novel vascular patches.

The rising awareness of cardiac diseases, surgeries and escalating healthcare infrastructures are also fueling the market. However, the growth is restrained by the dwindling numbers of surgeries, products failure and recalls, and associated risk of hematomas, severe bleeding and death.

Although, the overall growth of the vascular patches market is expected to leverage with the advancing medical technologies and excellent vascular patches materials, expanding patient population and awareness.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12868

The global vascular patches market is expected to escalate in coming years with its increasing adoption rate to treat cardiac complications, the medical advancements and availability of biocompatible vascular patches. By material, biological vascular patches lead the market with its high adoption rate due to the excellent biocompatibility, low risk of infections, safety and easy usage.

By application, carotid endarterectomy (CEA) rules the segment due to the elevated numbers of surgeries performed every year to prevent strokes and has high efficacy. By end-user, the hospital holds the largest share due to the highly sophisticated healthcare infrastructure, well experienced medical professionals and advanced patient care and surgeries.

The global vascular patches market is anticipated to be dominated by North America due to the huge geriatric population, surging cases prevalence of cardiac complications, advanced R&D and technology and awareness. Europe is expected to hold the second-largest vascular patches market with its diverse vascular patch products, high healthcare expenditure and infrastructure.

Asia-Pacific vascular patches market is expected to emerge as the fastest-growing market, driven by the escalating healthcare infrastructure, research, medical technologies, growing awareness, and giant patient pool.

Latin America vascular patches market is also expected to grow with the research and innovations of vascular and endovascular surgeries. Middle East &Africa vascular patches market are expected to elevate gradually with the progressing healthcare infrastructure.

The key players of vascular patches market include

  • B. Braun Melsungen AG
  • BD
  • LeMaitre
  • Baxter International
  • Getinge AB
  • VUP Medical
  • McKesson Medical-Surgical Inc.
  • CryoLife, Inc.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2015 – 2019
  • Market Size & Forecast 2020 to 2030
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12868

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
Key Segments

The global vascular patches market is segmented into material, application, end-user and region.

By material :

  • Biologic vascular patch
  • Synthetic vascular patch
By application:

  • Carotid endarterectomy (CEA)
  • Abdominal aortic aneurysms (AAA)
  • Coronary Artery Bypass Grafting (CABG)
  • Profundaplasty
  • Others
By end-user:

  • Hospital
  • Ambulatory surgical centres

Anti-Osteoporosis Therapy and Fracture Healing Market expected at a CAGR of ~ 3.8 % & US$ 12 Bn during the forecast period 2020–2030

Osteoporosis is a condition in which an individual starts losing his or her bone mass density. The condition increases the risk of bone cracks and fractures. There are several therapeutic options including oral drugs and injectable available for the treatment of osteoporosis. According to Future Market Insights (FMI), the anti-osteoporosis therapy and fracture healing market will register continued growth between 2020 and 2030. By the end of 2021, it is expected to surpass US$ 12 Bn.

Various leading market players are focusing on collaborative product development that has led to product innovation and availability of therapeutic options. For instance, GSK Consumer Healthcare has been established under single business following the completion of the merger of the consumer arms of GSK and Pfizer on August 1 in 2020

Rapidly growing ageing populations and rising prevalence of obesity expected to create considerable growth opportunities. The anti-osteoporosis therapy and fracture healing market is expected to grow significantly in terms of revenue over the forecast period owing to the increase in the availability of technologically advanced products options all over the world.

Moreover, stringent regulations are key restraints affecting growth of anti-osteoporosis therapy and fracture healing market. Side effects caused by osteoporosis drugs such as mild to fatal nausea, skin rashes, and others could affect growth of the market. Stringent regulations imposed by international organizations such as the U.S. Food and Drug Administration, which also conducts frequent revisions of side effects for osteoporosis drugs are challenging anti-osteoporosis therapy and fracture healing market growth.

Key Takeaways from Anti-osteoporosis Therapy and Fracture Healing Market Study

  • Anti-osteoporosis therapy and fracture healing market is expected to register 4.5% Y-o-Y growth in 2021
  • The demand from the U.S. is expected to be considerably, enabling it to account for a little below 90% of the North America market
  • The U.K. market is expected to register 5.4% Y-o-Y growth in 2021
  • France and Germany are likely to exhibit considerably high demand for anti-osteoporosis therapy and fracture healing
  • Within East Asia, both Japan and South Korea will emerge as key markets

Product Launches Remain Key Strategy

Product approvals by the U. S. FDA for anti-osteoporosis therapy and fracture healing drugs as well as injectable are expected to push towards high competition among market players. Numerous companies are focusing on advanced product development that is convenient to use and provide rapid efficacy in the treatment of osteoporosis.

For Instance, in April 2019, Amgen Inc. announced about approval of its EVENITY® by U.S. Food and Drug Administration (FDA) used in the treatment of postmenopausal women at high risk for fracture. According to FMI, oral drugs will continue accounting for the leading market share. Oral will remain highly preferred as route of drug administration, accounting for over 64% of the market in 2021.

Who is winning?

The global market is set to broaden its scope in the forecast period, stimulated by high prevalence rate of osteoporosis, rising geriatric population globally and adoption of advanced anti-osteoporosis therapy and fracture healing products which can be used for long term care needs. In addition to this, changing regulatory dynamics and patent expiry of blockbuster drugs has constrained the sales of anti-osteoporosis therapy and fracture healing products.

The key market players covered by FMI include Eli Lilly and Company, Pfizer, Inc., Amgen Inc., Merck and Company Inc., Novartis International AG, F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd. and GlaxoSmithKline Plc. consolidating their positions through mergers, acquisitions and new product launches.

anti osteoporosis therapy and fracture healing market key regions and drug mekko chart, 2020

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-1008

Anti-osteoporosis Therapy and Fracture Healing Market by CategoryDrug Type

  • Bisphosphonates
    • Osteoporosis
    • Others
  • Calcitonin
    • Osteoporosis
    • Others
  • Estrogen or Hormone Replacement Therapy
    • Osteoporosis
    • Others
  • Others
    • Osteoporosis
    • Others

Route of Administration

  • Oral
    • Osteoporosis
    • Others
  • Injectable
    • Osteoporosis
    • Others

Distribution Channel

  • Hospital Pharmacies
    • Osteoporosis
    • Others
  • Drug Stores
    • Osteoporosis
    • Others
  • Retail Pharmacies
    • Osteoporosis
    • Others
  • E-commerce
    • Osteoporosis
    • Others

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Disposable Spinal Instruments Market is estimated to be worth around US$ 59.7 Million in 2022

According to latest research by FMI, the global disposable spinal instruments market is estimated to have accounted for US$ 43.7 Mn in terms of value in 2018. The report on the disposable spinal instruments market further projects that the disposable spinal instruments market is likely to grow at a CAGR of 8.2% during the period 2019-2029.

Healthcare-Associated Infections or Hospital-Acquired Infections (HAIs) are caused while receiving medical treatment in a hospital facility. HAIs are among the major challenges to the safety of patients, and can have severe public health implications. These infections are also capable of causing disability and sometimes death. The occurrence of HAIs is increasing at an alarming rate. According to WHO, the prevalence of these infections in developed countries varies from 3.5% to 12%. Developing countries are at a higher risk as the rate of infection is 3-20 times higher in developing countries as compared to high-income countries.

In the U.S., more than 15 Mn surgeries are performed annually. Between 2% and 5% of patients are estimated develop a surgical site infection, which is between 160,000 and 300,000 surgical site infections nationwide each year. Surgical site infections are among the most commonly occurring HAIs in the U.S., and are the most expensive to treat. Fortunately, the adoption of various disposable devices and kits has reduced the incidence of surgical site infections and HAIs.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-6890

Thus, the increasing preference for the usage of disposable instruments for reducing the occurrence of HAIs is driving the demand for disposable instruments, which is creating growth opportunities for the disposable spinal instruments market.

The demand for disposable instruments kits in the healthcare industry is growing at a significant rate, and the demand from unconventional end-use industries is one of the major factors fuelling the market for disposable spinal instruments. Growth in the number of end users, apart from hospitals, such as orthopaedic clinics and Ambulatory Surgical Centres (ASCs), is expected to create high demand for disposable spinal instruments. Moreover, the adoption of disposable instrument kits by various end users has reduced the risk of infections and cross-contamination, which has resulted in a reduction in the number of HAIs.

Increase in the number of use cases of disposable spinal instruments in hospitals and ASCs is expected to boost the global demand for disposable instrument kits. According to CDC, the number of Medicare-certified ASCs has increased steadily from 239 in 1983 to 5,316 in 2010.

Moreover, increasing geriatric population, which is prone to various types of spinal injuries, is estimated to boost the need for surgeries. This is expected to contribute to the demand for disposable spinal instruments. The increasing requirement of instrument kits during surgeries among the greying population, coupled with improved life expectancy, has created significant growth opportunities for the manufactures of disposable spinal instruments market. However, factors such as stringent regulations and the generation of a significant amount of waste due to the usage of disposable kits is expected to lower the growth of disposable spinal instruments in the forecast period.

The disposable spinal instruments kits segment is a leading segment in terms of revenue by product type in the disposable spinal instruments market, with a 64.5% revenue share in 2018. These kits are most widely used in cervical and lumbar surgeries such as spinal fusion and decompression surgeries. Among the procedure type segments, the spinal fusion sub-segment accounts for the largest revenue share in the disposable spinal instruments market. Among all the end users in the disposable spinal instruments market, the hospitals sub-segment is expected to be a prominent segment, followed by the orthopaedic clinics sub-segment.

The disposable spinal instruments market has been analysed across the regions of North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA. North America, followed by Europe, is a prominent region in the global disposable spinal instruments market. North America accounted for a revenue share of 45.8% in 2018 in disposable spinal instruments market. Europe, accounting for the second-largest revenue share, is followed by East Asia in the disposable spinal instruments market. India, China, and Brazil are emerging markets in the disposable spinal instruments market. China is one of the fastest-growing emerging markets in the global disposable spinal instruments market, and is projected to grow at a CAGR of 11.2% over the forecast period of 2019-2029.

The disposable spinal instruments market report tracks some of the key companies operating in the disposable spinal instruments market, such as ECA Medical, Providence Medical Technology, Inc., Xenco Medical, Paradigm Spine, Intelligent Implant Systems, LLC, Safe Orthopaedics, SA , TeDan Surgical Innovations, LLC, and Joimax GmbH. Majority of the regional players in the disposable spinal instruments market are focused on increasing their product reach and connectivity with the regional distributors of disposable spinal instruments. The manufacturers of disposable spinal instruments are focusing on collaborating with established hospitals and ASCs to sell products as some of the medical practitioners are particular about the type and brand of products used for a surgical procedure.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-6890

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Fortified Yeast Market a new (FMI) study projects more than 13% CAGR for the market during 2021- 2029

Considering the global dietary supplement consumption trend, especially in developed countries, fortified yeast sales are most likely to remain on an upward trend over the following years. While B12 deficiency would remain key growth influencer for global fortified yeast market, a new Future Market Insights (FMI) study projects more than 13% CAGR for the market during 2019 – 2029.

UN projections indicate the world’s geriatric population to be exceeding 2 billion in 2050. Research suggests that elderly people are more prone to vitamin B12 deficiency, which may lead to improper mobility due to loss of neurological functions. Fortified food containing vitamin B12 lowers the risk of deficiency. Vitamin B12 fortified yeast is being marketed as an excellent vitamin B12 supplement via tablet or capsule.

Request a report sample to gain comprehensive market insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-10919

Key Takeaways – Fortified Yeast Market Study

  • Consumers are demanding products that are obtained from natural sources and have positive impact on their health. Fortified yeast contains vitamins, proteins, and fibres. It has cheesy and nutty flavours which enhance the taste of the food product it is added to.
  • Fortified yeast is available in different forms which include powder, flakes, tablet, and capsules. The powder form fortified yeast holds the major share in the market followed by flakes.
  • Over the course of forthcoming years, fortified yeast in capsule form is expected to show a significant growth due to increasing demand for nutritional supplements offered by fortified yeast.
  • The organic fortified yeast is still at an introductory phase but is expected to grow positively as the demand for the organic products among the consumers is growing at a very rapid pace which creates opportunities for organic fortified yeast to grow in the market.
  • The application of fortified yeast in the food & beverages segment contributes to more than 40% share in the overall fortified yeast market. Fortified yeast is used in snacks and daily food and is witnessing significantly rising demand. In addition to this, it finds application across various industries. For instance, the market witnesses demand from dietary supplement, personal care and other applications.
  • Western Europe is anticipated to dominate the global fortified yeast in terms of value share in the current scenario. The demand for fortified yeast has especially impacted the North America market, showing a higher growth over the forecast period.

The growth of the fortified yeast market is driven by a boom in veganism. Organic food ingredients are also gaining high traction owing to their various health benefits. This supports the growth of organic fortified yeast market. Manufacturers of fortified yeast need to focus on advertising and promotions to increase the knowledge and awareness about the benefits of fortified yeast consumption, to maximize profits and emerge as a leader in the fortified yeast market.

fortified yeast market region wise share

For Information On The Research Approach Used In The Report, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-10919

High Availability of Sugar Cane Molasses to Bolster Market Growth

Molasses, also known as blackstrap molasses, is a by-product of the sugar refining process from sugar cane, where one hundred tonnes of sugar cane generates around 3 tonnes of cane molasses. India, Brazil, and Thailand are some of the prominent countries in the sugar industry. Molasses fermentation is one of the processes for manufacture of inactive dried yeast, which is then fortified with other nutrients.

Gujarat (India) is a dry state, where blackstrap molasses is easily available for the manufacturing of yeast and yeast products.

Find More Valuable Insights on FMI’s Fortified Yeast Market Report

Future Market Insights, in its new offering, provides an unbiased analysis of the global fortified yeast market, presenting historical demand data (2014-2018) and forecast statistics for the period from 2019-2029. The study divulges compelling insights on the fortified yeast market based on the nature (organic and conventional) form (powder, flakes, tablet, capsules) applications (food & beverages, dietary supplements, personal care, and other applications), distribution channel (B2B and B2C) across seven major regions.

About Food Market Division at FMI

Expert analysis, actionable insights, and strategic recommendations – the food & beverage team at Future Market Insights helps clients from across the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analysed the food & beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

FORTIFIED YEAST MARKET TAXONOMY

The global fortified yeast market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

Nature

  • Organic
  • Conventional

Form

  • Powder
  • Flakes
  • Tablet
  • Capsule

Application

  • Food & Beverage
    • Bakery & Confectionery
    • Beverages
    • Soups, Sauces, & Seasonings
    • Functional Foods
    • Canned
  • Dietary Supplements
  • Personal Care
  • Other Applications

Distribution Channel

  • B2B
  • B2C
    • Modern Trade
    • Specialty Stores
    • Convenience Stores
    • Online Retail
    • Other Sales Channels

Region

  • North America
  • Latin America
  • Western Europe
  • North & Eastern Europe
  • Asia Pacific Excluding Japan
  • China
  • Middle East & Africa

Nutritional Yeast Market is projected to rise at a CAGR of ~14 between 2021 and 2029

A recent market study published by Future Market Insights on the nutritional yeast market offers global industry analysis for 2014-2018 & opportunity assessment for 2019-2029. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.

The global nutritional yeast market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

Nutritional Yeast Market By Product Type
  • Inactive Dry Yeast
  • Fortified Yeast
  • Revivable Yeast
Nutritional Yeast Market By Nature
  • Organic
  • Conventional
Nutritional Yeast Market By Form
  • Powder
  • Flakes
  • Tablet
  • Capsule
Nutritional Yeast Market By Application
  • Food & Beverage
    • Bakery & Confectionery
    • Beverages
    • Soups, Sauces & Seasonings
    • Functional Foods
  • Dietary Supplements
  • Personal Care
  • Animal Feed
  • Other Applications
Nutritional Yeast Market By Sales Channel
  • B2B
  • B2C
    • Modern Trade
    • Specialty Store
    • Convenience Store
    • Online Retail
    • Other Sales Channel

Download Free Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-10918

Nutritional Yeast Market By Region
  • North America
  • Latin America
  • Western Europe
  • North & Eastern Europe
  • APEC
  • China
  • Middle East & Africa
Nutritional Yeast market Analysis By Application
Frequently asked questions about global Nutritional Yeast market
Which application segment witnesses highest growth opportunities?

The food & beverage segment accounts for the maximum share in the nutritional yeast market. It is used as vegan meat and natural food flavor in food and beverages.

What is the critical trend influencing strategies adopted by manufacturers of nutritional yeast?

Veganism will be the most critical trend influencing production decisions of manufacturers. Manufacturers and retailers of nutritional yeast are marketing their products as vegan and meat substitutes to attract vegan consumers and improve their revenues.

What is the degree of competition in the nutritional yeast market?

Globally nutritional yeast is still at an introductory phase, therefore, more promotions and advertisements are required to spread awareness about its applications and health benefits. The nutritional yeast is widely used in food and beverage and dietary supplements. The vegan food products and plant-based proteins and ingredients markets are witnessing high growth rates due to which the demand for nutritional yeast is growing across the globe.

Which region will lead the global sales of nutritional yeast?

Western Europe remains the largest shareholder in the nutritional yeast market. However, Asia Pacific is expected to show higher growth.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/10918

Disposable Negative Pressure Wound Therapy Devices Market expected to reach US$ 461.3 Mn & ~ 10.7% CAGR through 2022-2028

In the report published by Future Market Insights titled “Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2017 – 2021) and Opportunity Assessment (2022 – 2028)”, it has been stated that the development around the globe in the last couple of years reflected certain complexities and fissures related to the political environment across many countries.

As protectionists are threatening to penetrate the notions of free-trade, globalization is likely to face its most difficult test ever. The threat of populist policies disrupting the decades-old trade agreements have grown bigger as the social and cultural rift between the bourgeoisie and proletariat is deepening with time.

While the preceding decades were marked by unison and formation of economic blocks, disintegration has been the story of the recent past. Although the business climate is far from favorable for organizations who have interest in multiple countries, the prevailing encounters have also obligated that corporate social responsibility becomes more than just a formality and companies actually demonstrate that they contribute to the societies they operate in.

There is a dire need for companies to participate in discussions and debates that will eventually lead to policy formulations. Owing to these circumstances the global disposable negative pressure wound therapy devices market is anticipated to witness a CAGR of 10.6% over the forecast period of 2022 and 2028.

2013-2021 Disposable Negative Pressure Wound Therapy Demand Outlook Compared to 2022-2028 Forecast

The Global disposable negative pressure wound therapy devices market is growing with the increasing prevalence of diabetes leading to diabetic ulcers & pressure sores. The continuously growing surgery numbers across the world leads to the consequential post-operative wounds, requiring negative pressure therapies and surgical site infections, becoming another reason for advanced usage of negative pressure wound therapy

The Global Disposable negative pressure wound therapy devices market constitutes nearly 9.2% of the ~2.47 Bn Negative Pressure Wound Therapy Market globally. Disposable negative pressure wound therapy allows clinicians for low exudating and small- to medium-sized wounds. The therapy is performed through a vacuum-assisted wound closure, which continuously or intermittently apply sub atmospheric pressure to the system, which in turn provides a positive pressure to the surface of a wound.

For instance, according to the American Diabetes Association (ADA), over 9–12 million Americans suffer from chronic ulcers, additionally, over 3% of the population older than 65 years have succumbed to some or other open wounds. It is been estimated that (US Government Estimates), by the year 2060, the elderly population will be over 77 million, signifying that chronic wounds will continue to be an increasingly persistent problem in this population. The consistent growth in burden of wound among population will enhance the interventions of negative pressure wound therapy

Hence, the demand outlook for disposable negative pressure wound therapy devices market is forecasted to grow at rapid rate during the forecast period owing to the growing demand for negative pressure wound therapy surgeries.

The disposable negative pressure wound therapy devices market is expected to expand at a considerable growth rate between 2022-2028 at a CAGR of around 10.7%, and observe an incremental $ opportunity of USD 210.6 Mn from 2022 to 2028. The hospitals segment will remain the most preferred option for surgeries conducted, during the forecast period.

disposable npwt devices market

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-6348

Cost Control Measures and Rising Healthcare Expenditure to Bode Well for the Market

The adoption rate of disposable NPWT devices is rising in developed nations such as the U.K., Germany, and the U.S., due to the obligation of healthcare burden across these countries owing to the growing prevalence of chronic wounds. According to an article on Wound Practice and Research, the healthcare expenditure for chronic wounds of 6.5 Mn patients accounts for over US$ 25 Bn per year in the U.S. Other research studies have also indicated that among chronic wounds, venous insufficiency ulcers constitute approximately 50% of the chronic leg ulcers. These wounds result due to venous etiology.

Annual prevalence of venous insufficiency ulcers in those aged 65 and above has been estimated to be near to 2 in every 100 persons per year. Prevalence of pressure ulcers varies between 0.31% and 0.70% per year in the United States.  Such cases are likely to boost the demand for disposable NPWT in the years to come.

Moreover, the growing focus on the expenditure pertaining to healthcare across developed as well as developing nations is expected to drive the adoption high quality patient care treatment options across the globe. This has also led to the rise in the per capita healthcare expenditure owing to the rising disposable income of people across the globe. This, is further expected to fuel the demand for wound care therapy and also increase the adoption of disposable NPWT devices in the course of the forecast period.

North America to Lead Among All Regions

North America is expected to stay on the vanguard during the forecast period in the global disposable NPWT devices market with a share of 51.1% in the overall market. The U.S. is expected to emerge as the most lucrative nation in North America closely trailed by Western Europe and Asia Pacific excluding Japan. Based on product type, the market has been bifurcated into disposable NPWT with canister and disposable NPWT without canister. On the basis of end user, the market has been segmented into hospitals, clinics, and homecare settings.

Market Players to Concentrate on Product Differentiation

The top players in the market are focusing on product differentiation and expansion of consumer base in order to retain their position in the market. The leading players accounted for over 77% of the global market share in 2016. The players are Acelity (Kinetic Concepts, Inc.), Cardinal Health Inc., Smith and Nephew PLC., ConvaTec Inc., and Medela.

Disposable Negative Pressure Wound Therapy- Market Segmentation – by Category

By Product:

  • Disposable NPWT with canister
  • Disposable NPWT without canister

By End user:

  • Hospitals
  • Clinics
  • Home care settings

Region:

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • APEJ
  • Japan
  • MEA

Yeast Extract Market is estimated to be valued at US$ 4,318.0 Million in 2022

Diverse application of different types of yeast extracts is driving market growth, and, as such, the global yeast extract market is witnessing rising demand, as consumers seek healthy food products derived from natural sources. The global yeast extract market is anticipated to be valued at US$ 1.1 Bn in 2019. Future Market Insights, a reputed name in the market research industry, projects that, the yeast extract market is expected to experience a growth rate of more than 6% in terms of value during the forecast period of 2019-2029.

Yeast products are mostly process-resistant, i.e., their composition does not get affected by processes when acid is introduced or during heating or freezing. This makes them appropriate for use in various applications across numerous industries such as food, beverages, cosmetics and personal care, nutraceuticals, pharmaceutical, and others. In the food and beverage industry, yeast extract is mainly used in soups, broths, fish, meat, analogue products, and seasonings.

There is high demand around the world for natural food products over synthetic and chemical food products, to prevent increasing lifestyle diseases. Thus, many food manufacturers are changing their manufacturing patterns and including more natural ingredients in their final products. This is the main factor expected to lead to the positive growth of the yeast extract market over the coming years.

Key Takeaways from Yeast Extract Market Study
  • According to FMI study’s on the yeast extract market, consumers seek products that are healthy and derived from different natural sources. Yeast extract is a kind of healthy food additive, which matches the growing consumer interest supporting their healthy lifestyle and healthy food.
  • The yeast extract market has been segmented on the basis of grade, where food grade yeast extract holds a major share. However, over the course of the coming years, feed grade yeast extract is expected to experience high growth due to its increasing demand from the feed industry.
  • Among the end-use industries the food and beverage industry contributes around 36.4% share in the overall yeast extract market. Yeast extract is used in soups, processed food, dairy food, bakery products, sauces, savory flavors, non- alcoholic beverages, and alcoholic beverages. In addition to this, it finds application across various other industries, such as the cosmetic and personal care industry.
  • Asia Pacific dominates the global yeast extract market in terms of value share, with both, Latin America and Asia Pacific expected to experience a high growth rate over the forecast period. China, especially, is exhibiting rising demand for yeast extract, owing to increasing consumer demand for premium food products with high flavor and taste.

Yeast Extract Market

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-10920

Yeast Extract Manufacturers Focusing on Product Innovation and Launches to Establish Strong Footprint

Manufacturers operating in the yeast extract are investing more in research & development activities to upscale their product innovation and improve their product portfolio. They are also focusing on increasing their sales footprint to serve consumers around the globe. Yeast extract manufacturers are expanding their supply chain to meet the demand from various end-use industries such as food and beverages, animal feed, pharmaceuticals, microbial nutrients, cosmetic and personal care, and other industries.

YEAST EXTRACT MARKET TAXONOMY

The global yeast extract market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

Grade

  • Food Grade
  • Feed Grade

End Use

  • Food and Beverages
    • Soups
    • Processed Food
    • Dairy Products
    • Bakery
    • Sauces & Savory Flavors
    • Non-alcoholic Beverages
    • Alcoholic Beverages
  • Animal Feed
  • Pharmaceuticals
  • Microbial Nutrients
  • Cosmetics & Personal Care
  • Others (Biofuel & Biomass Production)

Region

  • North America
  • Latin America
  • Europe
  • Middle East and Africa
  • Asia Pacific

Find More Valuable Insights on Yeast Extract Market

Future Market Insights, in its new offering, provides an unbiased analysis of the global yeast extract market, presenting historical demand data (2014-2018) and forecast statistics for the period of 2019-2029. The study divulges compelling insights on the yeast extract market based on grade (food and feed) end use (food and beverages, animal feed, pharmaceuticals, microbial nutrients, cosmetic and personal care, and other industries), across five major regions.

Cardiac Assist Devices Market expected at a CAGR of ~ 5.64% & US$ 2,062.7 Bn during the forecast period 2021–2031

ESOMAR-certified consulting firm Future Market Insights (FMI) forecasts steady growth for global cardiac assist devices over the assessment period between 2021 and 2031. The market is poised to expand at 5.29% CAGR, surpassing valuation of US$ 1231.8 Bn in 2021.

Driven by increasing demand for ventricular assist devices, the market is expected to register healthy growth in the upcoming decade. Surging cases of heart failure across the globe have resulted in increased demand for ventricular assist devices.

Technological advancements in ventricular assist devices intended to curb the mortality rate have driven the adoption in the U.S., the U.K., and Germany. Due to the benefits such as minimal hospital stays and fast recovery, demand for minimally invasive devices have improved the adoption of ventricular assist devices.

With rising prevalence of coronary heart diseases, demand for left ventricular assist devices in countries including the U.S. and the U.K., market is anticipated to witness billion-dollar opportunity during the forecast period.

Favorable government initiatives and fast-track approval for ventricular assist devices have improved the market demand, registering year-on-year growth at 5.90% CAGR in 2021.

2016-2020 Global Cardiac Assist Devices Market Outlook in Comparison to 2021-2031 Forecast

Cardiac Assist Devices Market recorded steady growth at 5.64% CAGR during the historical period of 2016 and 2020. Rising prevalence of heart failure across the globe resulted in increased demand for cardiac assist devices.

With mounting cases of coronary heart diseases, technological development in the field of ventricular assist devices is recognized as a key driver for the growth of the Cardiac Assist Devices Market.

As per FMI’s analysis, growth in cardiac assist devices is attributed to the growing prevalence of lifestyle disorders that are the major cause for cardiovascular diseases.

Cardiovascular diseases such as coronary heart disease and others have led to increased cases of heart failure, especially across the U.S., the U.K., and India. Every year around 6.2 million Americans die from heart failure, as per the data of Centers for Disease Control and Prevention.

Demand for heart transplantation have significantly increased due to the rising cases of heart failure. However, due to the unavailability of heart donor and long waiting list result in increased mortality rates.

Hence, patients are opting for ventricular assist devices for the treatment of heart failure. Due to the increased demand of ventricular assist devices, leading companies are continuously developing advanced cardiac assist devices catering the demand.

Key companies are adopting cutting-edge technologies such as artificial intelligence and internet of thinking to facilitate the rising demand and curb the mortality rates.

Due to the unprecedented outbreak of COVID-19, healthcare companies witnessed sudden boost due to the high demand for cardiac assist devices from hospital pharmacies. As per FMI, market witnessed a year-on-year (Y-o-Y) growth at 5.90% CAGR, topping US$ 1,231.8 Bn in 2021.

Request Complete TOC Of this Report @ https://www.futuremarketinsights.com/toc/rep-gb-467

cardiac assist devices market snapsot characteristics and attributes with regional relevance 2021-2031

Key Takeaways from FMI’s Cardiac Assist Devices Market Study

  • In terms of product type, ventricular assist devices (VAD) accounted for over 62% of global market share
  • Implantable devices are anticipated to capture maximum share owing to the ability to control, monitor and screen erratic heart rhythms
  • Hospital pharmacies are anticipated to hold major revenue share although ambulatory surgical center segment is expected to gain traction in the upcoming decade
  • The U.S. is anticipated to lead the global market owing to the increasing cases of heart failure resulting in surging demand for VAD
  • The U.K. and Germany are expected to dominate the Europe’s cardiac assist devices backed by technological development in the field of VAD
  • India is expected to emerge as highly lucrative market backed by favorable government initiatives and rising demand for minimally invasive devices

Competitive Landscape

Some of the leading healthcare companies are focusing on new product launches and innovation to stay ahead in the competition. As per Future Market Insights, Terumo Corporation, Medtronic PLC., Abbott Laboratories, Maquet GmbH, and Teleflex Incorporated are leading the market.

Key players are increasing the supply of ventricular assist devices catering the burgeoning demand, creating lucrative revenues. Increasing demand for artificial heart devices have led to consolidation of market by these top players.

However, new emerging players are adopting strategies including new launches and collaborations to gain the lead in the industry.

In June 2021, Medtronic PLC took the decision to stop the global sales of Medtronic Heartware HVAD left ventricular assist device (LVAD), which paved the way for many emerging players and leading players such as Abbott to increase the supply and capacity of LVADs.

In October 2020, another leading player, Abiomed announced the approval for its Impella CP Heart Pumps in Japan from Ministry of Health, Labor, and Welfare.

Cardiac assist devices Market by CategoryBy Product Type:

  • Ventricular Assist Devices (VAD)
    • Left Ventricular Assist Device (LVAD)
    • Right Ventricular Assist Device (RVAD)
    • Biventricular Assist Device (BIVAD)
    • External Ventricular Assist Devices
  • Intra-Aortic Balloon Pump

By Modality Type:        

  • Transcutaneous
  • Implantable

By End-User:

  • Hospital
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan (APEJ)
  • Japan
  • Middle East & Africa (MEA)